We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using PRP and Cord Blood in Treatment of Covid -19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04393415
Recruitment Status : Unknown
Verified July 2020 by Aljazeera Hospital.
Recruitment status was:  Recruiting
First Posted : May 19, 2020
Last Update Posted : July 27, 2020
Sponsor:
Information provided by (Responsible Party):
Aljazeera Hospital

Tracking Information
First Submitted Date  ICMJE May 15, 2020
First Posted Date  ICMJE May 19, 2020
Last Update Posted Date July 27, 2020
Actual Study Start Date  ICMJE May 25, 2020
Estimated Primary Completion Date August 25, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 15, 2020)		 the number of patients with positive covid 19 who will improve after receiving stem cells [ Time Frame: 2 weeks ]
patients with positive covid 19 who will improve after receiving stem cells
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Using PRP and Cord Blood in Treatment of Covid -19
Official Title  ICMJE the Effect of PRP and Cord Blood in Improving the Symptoms of Covid-19
Brief Summary covid - 19 is a critical viral infection that affects humans
Detailed Description Covid -19 pandemic started was declared in 2020
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Supportive Care
Condition  ICMJE Virus
Intervention  ICMJE Combination Product: stem cells
giving stem cells to patients with covid - 19
Study Arms  ICMJE
  • Active Comparator: patients receiving LGF
    Intervention: Combination Product: stem cells
  • No Intervention: patients not receiving LGF nor PRP
  • Active Comparator: patients receiving Platelet rich plasma
    Intervention: Combination Product: stem cells
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Unknown status
Estimated Enrollment  ICMJE
 (submitted: May 15, 2020)		 100
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE September 1, 2020
Estimated Primary Completion Date August 25, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • patients with positive covid -19 and has symptoms and isolated in the hospital

Exclusion Criteria:

  • patients with negative test for covid -19
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 20 Years to 70 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Egypt
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT04393415
Other Study ID Numbers  ICMJE covid -19
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE Not Provided
Current Responsible Party Aljazeera Hospital
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Aljazeera Hospital
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Mahmoud Alalfy, PhD Algezeera hospitaland National Research Centre ,Egypt
PRS Account Aljazeera Hospital
Verification Date July 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP